ArticleOncology reports2017

SLC3A2 is upregulated in human osteosarcoma and promotes tumor growth through the PI3K/Akt signaling pathway.

Bin Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.